Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Change in Cash (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of Change in Cash data on record, last reported at -$6.8 million in Q4 2025.

  • For Q4 2025, Change in Cash fell 251.0% year-over-year to -$6.8 million; the TTM value through Oct 2025 reached -$16.0 million, down 300.99%, while the annual FY2025 figure was -$8.8 million, 172.37% down from the prior year.
  • Change in Cash reached -$6.8 million in Q4 2025 per KEQU's latest filing, down from $3.3 million in the prior quarter.
  • Across five years, Change in Cash topped out at $14.6 million in Q3 2022 and bottomed at -$17.3 million in Q1 2025.
  • Average Change in Cash over 5 years is $371950.0, with a median of $17500.0 recorded in 2021.
  • Peak YoY movement for Change in Cash: tumbled 8126.15% in 2022, then surged 7096.67% in 2023.
  • A 5-year view of Change in Cash shows it stood at $65000.0 in 2021, then crashed by 8126.15% to -$5.2 million in 2022, then soared by 102.74% to $143000.0 in 2023, then soared by 3031.47% to $4.5 million in 2024, then plummeted by 251.0% to -$6.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were -$6.8 million in Q4 2025, $3.3 million in Q3 2025, and $4.8 million in Q2 2025.